Crane NXT, Co. (CXT) Stock Price & How to Invest

Crane NXT, Co. makes the physical things that prove something is real and that money is money. Its Security and Authentication Technologies segment contains Crane Currency, a roughly 225-year-old business that supplies banknote paper and micro-optic security features to the US Bureau of Engraving and Printing and to central banks abroad, plus Crane Authentication, the brand-protection and government-credential unit assembled from OpSec Security and the De La Rue Authentication business bought in May 2025 for ~300 million pounds. The Detection and Traceability Technologies segment holds Crane Payment Innovations, whose bill validators, coin mechanisms and cash-recycling hardware sit inside vending machines, slot machines, self-checkout lanes and bank branches, and now Antares Vision, the Italian inspection and track-and-trace supplier acquired on April 1, 2026 and delisted from Euronext Milan. The company became a standalone issuer on April 3, 2023, when Crane Holdings separated its aerospace, industrial and process-flow operations into Crane Company (NYSE: CR) and kept the payment and security businesses under the Crane NXT name.

The investment picture is a cheap-looking multiple attached to a business in the middle of a transformation. Second-quarter 2026 sales rose ~22% to ~$493 million, but only ~2.8% of that was organic: currency and authentication grew ~9.6% organically on strong international banknote demand, while the payment-acceptance side went backwards as retail and vending hardware orders stayed soft. Management raised full-year adjusted EPS guidance to ~$4.22 to ~$4.42 and held sales growth at ~15% to ~17%, which puts the stock near ~12x forward earnings at ~$52, roughly a quarter below its 52-week high. What the market appears to be discounting is that the growth is bought rather than earned, that net leverage of ~2.7x limits the next move, and that the gap between ~$1.10 of adjusted EPS and ~$0.61 of GAAP EPS in the quarter is mostly deal amortization that does not go away quickly.

The clearest risk is that headline growth is purchased and organic growth is barely positive, so a slower integration or a missed synergy target shows up immediately in the numbers with no underlying momentum to cushion it. Currency orders are lumpy, sovereign and budget-dependent, and a single delayed central-bank redesign or a change in US Bureau of Engraving and Printing timing can move a quarter. The payment-acceptance business faces a genuine secular question as cash usage declines in developed markets, and its retail and vending customers are cyclical hardware buyers. Net leverage near ~2.7x after three acquisitions narrows the room for a fourth or for a downturn, and the wide gap between adjusted and GAAP earnings (~$1.10 versus ~$0.61 in Q2 2026) reflects deal amortization and integration costs that will persist for years. Competition in authentication and traceability includes far larger diversified players, and the acquired businesses were sold by their previous owners for reasons the buyer now has to fix.

6 analysts publish price targets on CXT, averaging $70.17 against a $51.98 price as of August 2026, or +35.0%. The published targets run from $56.00 to $85.00, a moderate spread, and the ratings split 5 buy, 1 hold, 0 sell. Over the last six months there have been 0 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CXT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Crane NXT, Co.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Currency and authentication backlog at a record. The Security and Authentication segment posted ~$226.7 million of sales in Q2 2026, up ~9.6% organically, and ended the quarter with a record ~$498 million backlog. The most optimistic published target, $85.00, assumes this works close to its best case.

The case against. The clearest risk is that headline growth is purchased and organic growth is barely positive, so a slower integration or a missed synergy target shows up immediately in the numbers with no underlying momentum to cushion it. The most pessimistic target, $56.00, is roughly what CXT is worth if this bites instead.

Read the full bull and bear case on CXT, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Crane NXT, Co.'s investor relations page or your broker.

• Revenue (TTM): ~$1.80B
• Q2 2026 sales: ~$493M (+22% YoY, ~+2.8% organic)
• FY2026 adjusted EPS guidance: ~$4.22 to ~$4.42
• Market cap: ~$3.0B at ~$52 per share
• Forward P/E: ~12x guidance midpoint (trailing GAAP ~21x)
• Net leverage: ~2.7x adjusted EBITDA, guided to ~2.3x by year end

Q2 2026 adjusted EPS of ~$1.10 beat consensus near ~$1.04 and management lifted the full-year adjusted EPS range while leaving sales growth at ~15% to ~17% and adjusted EBITDA margin near ~24%. Total backlog reached ~$755 million, split ~$498 million in Security and Authentication and ~$257 million in Detection and Traceability. The stock trades roughly a quarter below its ~$69 52-week high, and the low forward multiple mainly reflects the market pricing acquisition-driven earnings and ~2.7x leverage more conservatively than organic earnings.

Other names that sit close to CXT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CXT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CXT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CXT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

CXT is a niche security-printing and authentication franchise being rebuilt through acquisition, priced cheaply because the organic engine underneath the deals has not yet shown it can grow.

Whether CXT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CXT a buy or a sell?, and where the stock could go from here in the CXT stock forecast.

For income investors, whether CXT pays a dividend and how the payout looks is covered in does CXT pay a dividend? And to weigh CXT against a peer, read the full side-by-side comparisons: CXT vs CR and CXT vs DBD.